Glucagon-Like Peptide-1 Receptor Agonists Are Not Associated With Increased Pulmonary Aspiration During Endoscopy and Colonoscopy
- 22 July 2026
- journal article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
Abstract
No abstract availableFunding Information
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK 083256-16)
This publication has 7 references indexed in Scilit:
- Association between glucagon‐like peptide‐1 receptor agonist use and peri‐operative pulmonary aspiration: a systematic review and meta‐analysisAnaesthesia, 2025
- Glucagon-like peptide-1 receptor agonist use and the risk of residual gastric contents and aspiration in patients undergoing GI endoscopy: a systematic review and a meta-analysisGastrointestinal Endoscopy, 2024
- Multisociety Clinical Practice Guidance for the Safe Use of Glucagon-like Peptide-1 Receptor Agonists in the Perioperative PeriodClinical Gastroenterology and Hepatology, 2024
- Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort studyBMJ, 2024
- Glucagon-Like Peptide Receptor Agonists Use Before Endoscopy Is Associated With Low Retained Gastric Contents: A Multicenter Cross-Sectional AnalysisAmerican Journal of Gastroenterology, 2024
- AGA Rapid Clinical Practice Update on the Management of Patients Taking GLP-1 Receptor Agonists Prior to Endoscopy: CommunicationClinical Gastroenterology and Hepatology, 2023
- Rates of infection after colonoscopy and osophagogastroduodenoscopy in ambulatory surgery centres in the USAGut, 2018